An award of Australia’s peak design assessment and promotion body, Standards Australia, the Australian International Design Award sets an international benchmark of design excellence and quality in manufactured goods.
The Salient Compact CT Contrast Injection System is used in radiology imaging procedures to precisely deliver contrast media that highlights tissue structures for diagnostic or therapeutic purposes. Delivery of contrast at high flow rates is essential for advanced imaging techniques with new generation fast CT scanners. Contrast media at high doses has been shown to affect kidney function. The Salient enables users to easily manipulate flow rate and volume, to minimise contrast dose and maximise contrast enhancement for each patient.
“We designed and developed the Salient injector entirely at our ISO certified facility in Sydney. Reliability and economy are critical in high volume radiology imaging practices. With this in mind we designed the Salient using high quality components and included features that provide convenience, ease-of-use and enable efficient servicing for a long operating life.” says Imaxeon Research and Development Manager, Mick Brooks.
According to radiographer Greg Cracknell, of Nepean Radiology, “The Salient injector is one of those unusual devices that combine economy, high-performance, reliability and convenience. The unit’s compact, cordless and manoeuvrable design is really valuable in our often over-crowded CT suite.”
The Salient Compact CT Contrast Injection System is available in Australia and New Zealand from Imaxeon. In Europe, Asia, Japan and Latin America the Salient is marketed by Imaxeon’s parent company, MEDRAD International.
For product information including a video on the Salient Compact CT Contrast Injection System visit: http://www.imaxeon.com/products/CT/Pages/Salient.aspx
Imaxeon Pty Ltd
Imaxeon manufactures and distributes worldwide, a range of contrast injection systems and consumables that are designed for radiology imaging procedures when economy, performance and convenience are required.
In Australia, Imaxeon supplies and supports healthcare facilities with high tech medical devices that enable or enhance diagnostic and therapeutic medical procedures for computed tomography, magnetic resonance, and cardiovascular applications. Imaxeon is a fully owned subsidiary of MEDRAD. http://www.medrad.com
P: +61 2 8845 4999